Largeot, A., Klapp, V., Viry, E., Gonder, S., Fernandez Botana, I., Blomme, A., Benzarti, M., Pierson, S., Duculty, C., Marttila, P., Wierz, M., Gargiulo, E., Pagano, G., An, N., El Hachem, N., Perez Hermandez, D., Chakraborty, S., Ysebaert, L., François, J.-H., ... Moussay, E. (2023). Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as therapeutic strategy in CLL. Blood. doi:10.1182/blood.2022017839 |
Blomme, A., Peter, C., Mui, E., Rodriguez Blanco, G., An, N., Mason, L. M., Jamieson, L. E., McGregor, G. H., Lilla, S., Ntala, C., Patel, R., Thiry, M., Kung, S. H. Y., Leclercq, M., Ford, C. A., Rushworth, L. K., McGarry, D. J., Mason, S., Repiscak, P., ... Leung, H. Y. (2022). THEM6-mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer. EMBO Molecular Medicine, 14764. doi:10.15252/emmm.202114764 |
An, N., Wang, H., Jing, W., Zhu, H., & Yu, J. (September 2019). Local Consolidative Radiation Prolongs Disease Control of Patients with Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated with First-Line EGFR-TKIs. International Journal of Radiation Oncology*Biology*Physics, 105 (1), 494-E495. doi:10.1016/j.ijrobp.2019.06.1402 |
Wang, H., An, N., Liu, Y., Hu, X., & Hou, M. (June 2019). PS1485 TRAMETINIB RESTORES IMMUNE TOLERANCE IN ITP PATIENTS BY MODULATING IRF4-MEDIATED TH1 AND TREG CELLS. HemaSphere, 3 (S1), 684-685. doi:10.1097/01.hs9.0000564200.10394.84 |
An, N., Wang, H., Jia, W., Jing, W., Liu, C., Zhu, H., & Yu, J. (2019). The prognostic role of circulating CD8+ T cell proliferation in patients with untreated extensive stage small cell lung cancer. Journal of Translational Medicine, 17 (1), 402. doi:10.1186/s12967-019-02160-7 |
An, N., Wang, H., Li, J., Zhai, X., Jing, W., Jia, W., Kong, L., Zhu, H., & Yu, J. (2019). Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective Study. OncoTargets and Therapy, 12, 8311-8318. doi:10.2147/OTT.S223216 |
An, N., Wang, H., Zhu, H., Yan, W., Jing, W., Kong, L., Zhang, Y., & Yu, J. (2019). Great efficacy of afatinib on a patient with lung adenocarcinoma harboring uncommon EGFR delE709_T710insD mutations: a case report. OncoTargets and Therapy, 12, 7399-7404. doi:10.2147/OTT.S221638 |
Liu, C., Jing, W., An, N., Li, A., Yan, W., Zhu, H., & Yu, J. (2019). Prognostic significance of peripheral CD8+CD28+ and CD8+CD28- T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy. Journal of Translational Medicine, 17 (1), 344. doi:10.1186/s12967-019-2097-7 |
An, N., Jing, W., Wang, H., Li, J., Liu, Y., Yu, J., & Zhu, H. (2018). Risk factors for brain metastases in patients with non-small-cell lung cancer. Cancer Medicine, 7 (12), 6357-6364. doi:10.1002/cam4.1865 |
Tang, S.-H., Wang, H.-Y., Sun, H., An, N., Xiao, L., Sun, Q., & Zhao, D.-B. (February 2017). Propofol inhibits carbachol-induced chloride secretion by directly targeting the basolateral K+ channel in rat ileum epithelium. Neurogastroenterology and Motility, 29 (2), 12934. doi:10.1111/nmo.12934 |
Wang, B.* , An, N.* , Shaikh, A. S., Wang, H., Xiao, L., Liu, H., Li, J., & Zhao, D. (2017). Hyperosmolarity evokes histamine release from ileum mucosa by stimulating a cholinergic pathway. Biochemical and Biophysical Research Communications, 493 (2), 1037-1042. doi:10.1016/j.bbrc.2017.09.093 * These authors have contributed equally to this work. |